Tracy L. Hartman

1.0k citations

36 papers · 874 indexed · h-index 18

Co-authors: Robert W. Buckheit Christophe Pannecouque Erik De Clercq Mark Cushman Karen Watson Jim A. Turpin Bo‐Liang Deng Matthew D. Cullen
Topics: HIV/AIDS drug development and treatment (26 papers)HIV Research and Treatment (25 papers)Pneumocystis jirovecii pneumonia detection and treatment (7 papers)
Cited by: Virology Infectious Diseases Organic Chemistry
Journals: SHILAP Revista de lepidopterologíaJournal of Medicinal Chemistry Antimicrobial Agents and Chemotherapy
Partner nations: United States Belgium South Korea

In The Last Decade

Tracy L. Hartman

35 papers receiving 844 citations

Peers

Countries citing papers authored by Tracy L. Hartman

Since Specialization

Citations

This map shows the geographic impact of Tracy L. Hartman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tracy L. Hartman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tracy L. Hartman more than expected).

Fields of papers citing papers by Tracy L. Hartman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tracy L. Hartman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tracy L. Hartman. The network helps show where Tracy L. Hartman may publish in the future.

Co-authorship network of co-authors of Tracy L. Hartman

This figure shows the co-authorship network connecting the top 25 collaborators of Tracy L. Hartman. A scholar is included among the top collaborators of Tracy L. Hartman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tracy L. Hartman. Tracy L. Hartman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The structure-activity profile of mercaptobenzamides’ anti-HIV activity suggests that thermodynamics of metabolism is more important than binding affinity to the target 2019 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),Michael T. Scerba,(unknown),(unknown),Tracy L. Hartman,(unknown),Robert W. Buckheit,Stewart R. Durell,Daniel H. Appella	6
2	Preclinical evaluation of a mercaptobenzamide and its prodrug for NCp7-targeted inhibition of human immunodeficiency virus 2016 ·Antiviral Research ·Tracy L. Hartman,Liyuan Yang,(unknown),Matthew Hassink,(unknown),(unknown),Michael T. Scerba,(unknown),Emma Hughes,(unknown),Xin Xu,Pankaj Gupta,Robert W. Buckheit,Daniel H. Appella	14
3	Systematic evaluation of methyl ester bioisosteres in the context of developing alkenyldiarylmethanes (ADAMs) as non-nucleoside reverse transcriptase inhibitors (NNRTIs) for anti-HIV-1 chemotherapy 2016 ·Bioorganic & Medicinal Chemistry ·(unknown),Takeshi Sakamoto,Jun Takayama,(unknown),Mari Okazaki,Tracy L. Hartman,Robert W. Buckheit,Christophe Pannecouque,Mark Cushman	7
4	An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation 2016 ·Antiviral Research ·Ryan P. Bennett,(unknown),(unknown),Roger G. Ptak,Marie K. Mankowski,Tracy L. Hartman,Robert W. Buckheit,Beth A. Snyder,Jason D. Salter,Guillermo A. Morales,Harold C. Smith	28
5	Anti-HSV activity of serpin antithrombin III. 2014 ·PubMed ·Debra C. Quenelle,Tracy L. Hartman,Robert W. Buckheit,Mark N. Prichard,(unknown)	6
6	Antiviral interactions of combinations of highly potent 2,4(1H,3H)-pyrimidinedione congeners and other anti-HIV agents 2011 ·Antiviral Research ·Tracy L. Hartman,Lu Yang,Robert W. Buckheit	7
7	Was the Pediatric Emergency Department or Pediatric Urgent Care Center Setting More Affected by the Fall 2009 H1N1 Influenza Outbreak? 2011 ·Clinical Pediatrics ·Gregory P. Conners,Tracy L. Hartman,(unknown),Lisa L. Schroeder,(unknown)	4
8	Multivalent binding oligomers inhibit HIV Tat–TAR interaction critical for viral replication 2009 ·Bioorganic & Medicinal Chemistry Letters ·Deyun Wang,(unknown),Heather L. Baker,(unknown),Roger G. Ptak,Lu Yang,Tracy L. Hartman,Robert W. Buckheit,(unknown),Ao Yang,Pascale Legault,Venkat R. K. Yedavalli,Kuan‐Teh Jeang,Daniel H. Appella	11
9	Crystallographic Study of a Novel Subnanomolar Inhibitor Provides Insight on the Binding Interactions of Alkenyldiarylmethanes with Human Immunodeficiency Virus-1 Reverse Transcriptase 2009 ·Journal of Medicinal Chemistry ·Matthew D. Cullen,William C. Ho,Joseph D. Bauman,Kalyan Das,Eddy Arnold,Tracy L. Hartman,Karen Watson,Robert W. Buckheit,Christophe Pannecouque,Erik De Clercq,Mark Cushman	9
10	Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo[d]isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors 2008 ·European Journal of Medicinal Chemistry ·Bo‐Liang Deng,Yujie Zhao,Tracy L. Hartman,Karen Watson,Robert W. Buckheit,Christophe Pannecouque,Erik De Clercq,Mark Cushman	28
11	Inhibition of tubulin polymerization by select alkenyldiarylmethanes 2007 ·Bioorganic & Medicinal Chemistry Letters ·Matthew D. Cullen,Taradas Sarkar,Ernest Hamel,Tracy L. Hartman,Karen Watson,Robert W. Buckheit,Christophe Pannecouque,Erik De Clercq,Mark Cushman	7
12	Synthesis and Biological Evaluation of Alkenyldiarylmethane HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors That Possess Increased Hydrolytic Stability 2007 ·Journal of Medicinal Chemistry ·Matthew D. Cullen,Bo‐Liang Deng,Tracy L. Hartman,Karen Watson,Robert W. Buckheit,Christophe Pannecouque,Erik De Clercq,Mark Cushman	26
13	Carrageenan/MIV-150 (PC-815), a Combination Microbicide 2006 ·Sexually Transmitted Diseases ·José A. Fernández-Romero,(unknown),Stuart Turville,Kanani Titchen,(unknown),Jifan Li,Todd Miller,Melissa Robbiani,Robin Maguire,Robert W. Buckheit,Tracy L. Hartman,David M. Phillips	75
14	Synthesis and anti-HIV activity of new alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors (NNRTIs) incorporating benzoxazolone and benzisoxazole rings 2005 ·Bioorganic & Medicinal Chemistry ·Bo‐Liang Deng,Matthew D. Cullen,Zhigang Zhou,Tracy L. Hartman,Robert W. Buckheit,Christophe Pannecouque,Erik De Clercq,Phillip E. Fanwick,Mark Cushman	77
15	Potent inhibition of HIV-1 entry by (s4dU)35 2005 ·Virology ·András Horváth,(unknown),Tracy L. Hartman,Karen Watson,Jim A. Turpin,Robert W. Buckheit,Zsolt Sebestyén,János Szöllõsi,Ilona Benkő,Thomas J. Bardos,Joseph A. Dunn,László Fésüs,Ferenc Tóth,János Aradi	16
16	Optimization of unique, uncharged thioesters as inhibitors of HIV replication 2004 ·Bioorganic & Medicinal Chemistry ·Pratibha Srivastava,Marco Schito,Rasem Fattah,Toshiaki HARA,Tracy L. Hartman,Robert W. Buckheit,Jim A. Turpin,John K. Inman,Ettore Appella	37
17	Synthesis of alkenyldiarylmethane (ADAM) non-Nucleoside HIV-1 reverse transcriptase inhibitors with non-Identical aromatic rings 2002 ·Bioorganic & Medicinal Chemistry ·Guozhang Xu,Tracy L. Hartman,(unknown),Jim A. Turpin,Robert W. Buckheit,Mark Cushman	17
18	Benzamide-Based Thiolcarbamates: A New Class of HIV-1 NCp7 Inhibitors 2002 ·Bioorganic & Medicinal Chemistry Letters ·Atul Goel,Sharlyn J. Mazur,Rasem Fattah,Tracy L. Hartman,Jim A. Turpin,Mingjun Huang,William G. Rice,Ettore Appella,John K. Inman	106
19	Synthesis of substituted diarylmethylenepiperidines (DAMPs), a novel class of anti-HIV agents 2002 ·Bioorganic & Medicinal Chemistry ·Guozhang Xu,(unknown),Tracy L. Hartman,(unknown),Karen Watson,Jim A. Turpin,Robert W. Buckheit,Allison A. Johnson,Yves Pommier,Mark Cushman	11
20	The Biological Effects of Structural Variation at the Meta Position of the Aromatic Rings and at the End of the Alkenyl Chain in the Alkenyldiarylmethane Series of Non-Nucleoside Reverse Transcriptase Inhibitors 2001 ·Journal of Medicinal Chemistry ·Guozhang Xu,(unknown),(unknown),Tracy L. Hartman,(unknown),(unknown),(unknown),Jim A. Turpin,Robert W. Buckheit,Mark Cushman	28

About Tracy L. Hartman

Tracy L. Hartman is a scholar working on Virology, Infectious Diseases and Library and Information Sciences, having authored 36 papers that have together received 874 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (26 papers), HIV Research and Treatment (25 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). The work is most often cited by research in Virology (265 citations), Infectious Diseases (348 citations) and Organic Chemistry (387 citations). Tracy L. Hartman has collaborated with scholars based in United States, Belgium and South Korea. Frequent co-authors include Robert W. Buckheit, Christophe Pannecouque, Erik De Clercq, Mark Cushman, Karen Watson, Jim A. Turpin, Bo‐Liang Deng, Matthew D. Cullen, Rasem Fattah and Ettore Appella. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact